Liver Disease Diagnostics Market Anticipated to Reach $48.7 Billion By 2027 | Grand View Research, Inc

 Breaking News
  • No posts were found

Liver Disease Diagnostics Market Anticipated to Reach $48.7 Billion By 2027 | Grand View Research, Inc

August 12
10:54 2020
Liver Disease Diagnostics Market Anticipated to Reach $48.7 Billion By 2027 | Grand View Research, Inc

Grand View Research, Inc. – Market Research And Consulting.
According to report published by Grand View Research, the global liver disease diagnostics market size was valued at USD 29.3 billion in 2019 and is estimated to grow at a compound annual growth rate (CAGR) of 6.5% from 2020 to 2027.

The global liver disease diagnostics market size is anticipated to reach USD xx billion by 2027, expanding at a CAGR of 6.5% according to a new report by Grand View Research, Inc. Rise in chronic liver diseases is one of the major growth factors for diagnostics market. The rise in mortality rates supplements the need for liver diagnostics as there is a high prevalence of liver cancer throughout the world population.

Increase in liver biopsy and laboratory tests is anticipated to enhance the market growth in the long term. Increasing R&D is expected to speed up the market developments. Companies are now engaging in collaboration to enhance the quality of patient care, thereby supplementing the market growth in the following years to come. Recently, in October 2019, Perspectum Diagnostics partnered with Precious Medical Center, Singapore, to offer liver multi scan. This was done in the light of creating awareness among the general population to undertake routine health-check up under prevailing liver conditions, and also to encourage timely liver screening.

Development of accurate diagnostic methods and collaborative approach undertaken by key players is expected to boost the market. Additionally, extensive research conducted by researchers to figure out various measures to differentiate between malignant and benign lesions is anticipated to supplement the market with various treatment options.

Browse Details of Report, Please Visit @

U.S liver disease diagnostics market size, by diagnosis technique, 2016-2027 (USD Billion)

Covid-19 Effect:

According to a medical survey, it is found that advanced cirrhosis increases the chance of mortality by coronavirus. The survey was carried by liver specialists in Europe, North America and Asia. However, researchers are still unclear if there’s any relation between covid-19 and clinical outcome of people with chronic liver disease. Although, based on the available information the elderly population with underlying medical conditions are at a higher risk for SARS-COV2 based on the assumption if medical conditions are not well addressed.

Further key findings from the report suggest:

  • Imaging segment accounted for a high revenue share in 2019 based on strategic initiatives undertaken by the key players. There has been a growing demand for CT-scan, ultrasound and MRI techniques in the forecast period 
  • Based on end-use, the liver disease diagnostics market can be segmented as hospitals, laboratories, and others. Hospitals held a dominant position in 2019 owing to the essential facilities and infrastructure for patient care. Laboratories are expected to grow at a steady rate in the near future 
  • North America is a dominant market attributing to a high revenue share. Massive investments by key players for clinical research has led in a robust development of healthcare facilities in the U.S. 
  • Key players are adopting innovative strategies to maintain a high competitive advantage.

Global liver disease diagnostics market share, by enduse, 2019 (%)

Request For Free Sample Report @

 Major Key Players:

  • Abbott

  • Fujifilm Corporation

  • Thermo Fisher Scientific Inc.

  • F. Hoffmann-La Roche Ltd.

  • Boston Scientific Corporation

  • Laboratory Corporation of America Holdings

  • Horiba Medical

  • Siemens Healthcare GmbH

  • Randox Laboratories Ltd.

Have Inquiry before buying about this report, our team of analyst will be glad to help!

Liver Disease Diagnostics Market Segmentation

Grand View Research has segmented the global liver disease diagnostics market on the basis of diagnosis technique, end use, and region:

Liver Disease Diagnostics Diagnosis Technique Outlook (Revenue, USD Million, 2016 – 2027)

  • Imaging
  • Laboratory tests
  • Endoscopy
  • Biopsy
  • Others

Liver Disease Diagnostics End-use Outlook (Revenue, USD Million, 2016 – 2027)

  • Hospitals
  • Laboratories
  • Others

Liver Disease Diagnostics Regional Outlook (Revenue, USD Million, 2016 – 2027)

  • North America
    • U.S
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Singapore
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • UAE

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.


Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States

Related Articles


January 2022